Tribunal decisions on tax appeals: deductions upheld, disallowances deleted, transfer pricing issue remitted.

The tribunal partly allowed the assessee's appeals, dismissing the Revenue's appeal. The Assessing Officer was directed to re-compute certain claims and delete specific disallowances based on judicial precedents and factual findings. Key decisions included upholding deductions for clinical trial expenditure and foreign currency loss, rejecting claims for certain deductions due to lack of evidence or non-pressing of grounds, and deleting disallowances related to interest and sales promotion expenditure. The tribunal also remitted the transfer pricing adjustment issue back to the Assessing Officer for fresh adjudication.

---

---

Issues Involved:
1. Disallowance of Section 80HHC deduction claim.
2. Disallowance of prior period expenditure.
3. Transfer pricing adjustment addition.
4. Disallowance of depreciation related to foreign exchange loss.
5. Disallowance of Section 35(2AB) deduction claim.
6. Disallowance of Section 80G deduction claim.
7. Upward transfer pricing adjustment of corporate guarantee fee.
8. Section 36(1)(iii) interest disallowance.
9. Disallowance of Section 35(2AB) deduction for clinical trial expenditure.
10. Disallowance of foreign currency loss as speculation loss.
11. Disallowance of sales promotion expenditure under Section 37(1).
12. Disallowance of product registration expenditure as capital in nature.

Detailed Analysis:

1. Disallowance of Section 80HHC Deduction Claim:
The assessee's Section 80HHC deduction claim of Rs. 18,85,093 was disallowed by the Assessing Officer and CIT(A) based on legislative amendments and negative profit figures. The tribunal found that the CIT(A) did not consider the net profit element in DEPB income, contrary to the Supreme Court’s decision in Topman Exports. Additionally, the Gujarat High Court’s judgment in Avani Exports quashing the retrospective amendments was upheld by the Supreme Court. The tribunal directed the Assessing Officer to re-compute the deduction claim.

2. Disallowance of Prior Period Expenditure:
The assessee's claim for prior period expenses of Rs. 10,83,885 was disallowed due to lack of evidence of crystallization in the relevant year. The tribunal observed that the expenses were genuine and incurred in the relevant year due to delayed receipt of bills. Following the Gujarat High Court’s decision in Adani Enterprises, the tribunal deleted the disallowance since the assessee was taxed at a uniform rate.

3. Transfer Pricing Adjustment Addition:
The tribunal remitted the issue of transfer pricing adjustment of Rs. 38,14,000 back to the Assessing Officer for fresh adjudication, aligning with the tribunal’s order in preceding assessment years.

4. Disallowance of Depreciation Related to Foreign Exchange Loss:
The tribunal upheld the disallowance of depreciation related to foreign exchange loss of Rs. 42,66,137, following the tribunal’s earlier decision for assessment year 2002-03.

5. Disallowance of Section 35(2AB) Deduction Claim:
The tribunal rejected the assessee’s claim for Section 35(2AB) deduction of Rs. 5,34,000 as the assessee did not press the corresponding ground in lower appellate proceedings.

6. Disallowance of Section 80G Deduction Claim:
The tribunal rejected the assessee’s claim for Section 80G deduction of Rs. 3,50,000 due to the absence of relevant receipts and their nexus with the business.

7. Upward Transfer Pricing Adjustment of Corporate Guarantee Fee:
The tribunal deleted the upward transfer pricing adjustment of Rs. 60,83,440, following its earlier decision that such corporate guarantee adjustments are not international transactions under Section 92B.

8. Section 36(1)(iii) Interest Disallowance:
The tribunal deleted the interest disallowance of Rs. 1,68,88,558, following judicial precedents that strategic interest-free advances to sister concerns are not disallowable if the assessee is assessed at the same rate.

9. Disallowance of Section 35(2AB) Deduction for Clinical Trial Expenditure:
The tribunal deleted the disallowance of Rs. 4,59,11,880 for clinical trial expenditure, following the Gujarat High Court’s decision that such expenses qualify for weighted deduction under Section 35(2AB).

10. Disallowance of Foreign Currency Loss as Speculation Loss:
The tribunal deleted the disallowance of foreign currency loss of Rs. 25,39,60,000, treating it as a business loss rather than speculation loss, aligning with judicial precedents that hedging transactions in the course of import-export activities are business losses.

11. Disallowance of Sales Promotion Expenditure Under Section 37(1):
The tribunal deleted the disallowance of sales promotion expenditure of Rs. 10,89,29,928, following the tribunal’s decision in PHL Pharma Pvt. Ltd. that such expenses are allowable as business expenditure and not hit by Section 37(1) explanation.

12. Disallowance of Product Registration Expenditure as Capital in Nature:
The tribunal upheld the DRP’s decision treating product registration expenditure of Rs. 3,65,93,107 as revenue expenditure, following the co-ordinate bench and Gujarat High Court’s decision in the assessee’s favor for assessment year 2006-07.

Conclusion:
The tribunal partly allowed the assessee’s appeals and dismissed the Revenue’s appeal, directing the Assessing Officer to re-compute certain claims and delete specific disallowances based on judicial precedents and factual findings.

---